Response-adaptive dose-finding under model uncertainty

34 mins 57 secs, 484.91 MB, MPEG-4 Video 640x360, 29.97 fps, 44100 Hz, 1.84 Mbits/sec

Share this media item:

Embed this media item:

<iframe width="_width_" height="_height_" src="https://sms.cam.ac.uk/media/1166195/embed" frameborder="0" scrolling="no" allowfullscreen></iframe>

Choose size:

About this item

Available Formats

About this item

Response-adaptive dose-finding under model uncertainty's image

Description:	Bretz, F (Novartis) Tuesday 16 August 2011, 14:00-14:30

Created:

2011-08-22 13:49

Collection:

Design and Analysis of Experiments
Open for Business: Pharmaceutical Day

Publisher:

Isaac Newton Institute

Bretz, F

Language:

eng (English)

Credits:

Author:	Bretz, F
Director:	Steve Greenham


Abstract:	In pharmaceutical drug development, dose-finding studies are of critical importance because both safety and clinically relevant efficacy have to be demonstrated for a specific dose of a new compound before market authorization. Motivated by a real dose-finding study, we propose response-adaptive designs addressing two major challenges in dose-finding studies: uncertainty about the dose-response models and large variability in parameter estimates. To allocate new cohorts of patients in an ongoing study, we use optimal designs that are robust under model uncertainty. In addition, we use a Bayesian shrinkage approach to stabilize the parameter estimates over the successive interim analyses used in the adaptations. This approach allows us to calculate updated parameter estimates and model probabilities that can then be used to calculate the optimal design for subsequent cohorts. The resulting designs are hence robust with respect to model misspecification and additionally can ef ficiently adapt to the information accrued in an ongoing study. We focus on adaptive designs for estimating the minimum effective dose, although alternative optimality criteria or mixtures thereof could be used, enabling the design to address multiple objectives. In an extensive simulation study, we investigate the operating characteristics of the proposed method under a variety of scenarios.

Abstract:

In pharmaceutical drug development, dose-finding studies are of critical importance because both safety and clinically relevant efficacy have to be demonstrated for a specific dose of a new compound before market authorization. Motivated by a real dose-finding study, we propose response-adaptive designs addressing two major challenges in dose-finding studies: uncertainty about the dose-response models and large variability in parameter estimates. To allocate new cohorts of patients in an ongoing study, we use optimal designs that are robust under model uncertainty. In addition, we use a Bayesian shrinkage approach to stabilize the parameter estimates over the successive interim analyses used in the adaptations. This approach allows us to calculate updated parameter estimates and model probabilities that can then be used to calculate the optimal design for subsequent cohorts. The resulting designs are hence robust with respect to model misspecification and additionally can ef ficiently adapt to the information accrued in an ongoing study. We focus on adaptive designs for estimating the minimum effective dose, although alternative optimality criteria or mixtures thereof could be used, enabling the design to address multiple objectives. In an extensive simulation study, we investigate the operating characteristics of the proposed method under a variety of scenarios.

Available Formats

Format	Quality	Bitrate	Size
MPEG-4 Video *	640x360	1.84 Mbits/sec	484.91 MB	View	Download
WebM	640x360	1.03 Mbits/sec	271.37 MB	View	Download
Flash Video	484x272	568.79 kbits/sec	145.60 MB	View	Download
iPod Video	480x270	506.31 kbits/sec	129.61 MB	View	Download
MP3	44100 Hz	125.02 kbits/sec	31.81 MB	Listen	Download
Auto	(Allows browser to choose a format it supports)